XML 59 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Restaurant Information by Ownership Type
The following table presents restaurant information by ownership type:
Restaurants at December 31,202120202019
Conventional franchised21,607 21,712 21,837 
Developmental licensed7,913 7,663 7,648 
Foreign affiliated7,775 7,146 6,574 
    Total Franchised37,295 36,521 36,059 
    Company-operated2,736 2,677 2,636 
Total Systemwide restaurants40,031 39,198 38,695 
Activity in Goodwill by Segment
The following table presents the 2021 activity in goodwill by segment:
In millionsU.S.International
Operated Markets
International Developmental Licensed Markets & CorporateConsolidated
Balance at December 31, 2020$1,625.5 $1,147.6 $— $2,773.1 
Net restaurant purchases (sales)47.9 16.9 — 64.8 
Currency translation— (55.4)— (55.4)
Balance at December 31, 2021$1,673.4 $1,109.1 $ $2,782.5 
Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
The following tables present financial assets and liabilities measured at fair value on a recurring basis by the valuation hierarchy as defined in the fair value guidance:
December 31, 2021
In millions
Level 1 (1)
Level 2Carrying
Value
Derivative assets$209.8 $79.8 $289.6 
Derivative liabilities$(7.9)$(7.9)
December 31, 2020
In millions
Level 1 (1)
Level 2Carrying
Value
Derivative assets$185.6 $41.4 $227.0 
Derivative liabilities$(97.5)$(97.5)
(1)    Level 1 is comprised of derivatives that hedge market driven changes in liabilities associated with the Company’s supplemental benefit plans.
Fair Values of Derivative Instruments Included on Consolidated Balance Sheet The following table presents the fair values of derivative instruments included on the Consolidated Balance Sheet as of December 31, 2021 and 2020:
  Derivative AssetsDerivative Liabilities
In millionsBalance Sheet Classification20212020Balance Sheet Classification20212020
Derivatives designated as hedging instruments
Foreign currency
Prepaid expenses and other current assets
$42.4 $— 
Accrued payroll and other liabilities
$(3.3)$(64.5)
Interest rate
Prepaid expenses and other current assets
0.3 — 
Accrued payroll and other liabilities
 — 
Foreign currencyMiscellaneous other assets28.0 5.6 Other long-term liabilities(0.5)(15.0)
Interest rateMiscellaneous other assets8.6 35.8 Other long-term liabilities(4.1)— 
Total derivatives designated as hedging instruments$79.3 $41.4  $(7.9)$(79.5)
Derivatives not designated as hedging instruments
EquityPrepaid expenses and other current assets$9.5 $185.6 
Accrued payroll and other liabilities
$ $(8.6)
Foreign currencyPrepaid expenses and other current assets0.5 — 
Accrued payroll and other liabilities
 (9.4)
EquityMiscellaneous other assets200.3 —  
Total derivatives not designated as hedging instruments$210.3 $185.6  $ $(18.0)
Total derivatives$289.6 $227.0  $(7.9)$(97.5)
Derivatives Pretax Amounts Affecting Income and Other Comprehensive Income
The following table presents the pre-tax amounts from derivative instruments affecting income and AOCI for the year ended December 31, 2021 and 2020, respectively:
Location of gain or loss
recognized in income on
derivative
Gain (loss)
recognized in
AOCI
Gain (loss) reclassified
into income from AOCI
Gain (loss) recognized in
income on derivative
In millions202120202021202020212020
Foreign currencyNonoperating income/expense$74.2 $(76.6)$(30.9)$(2.1)
Interest rateInterest expense (90.8)(6.3)(5.4)
Cash flow hedges$74.2 $(167.4)$(37.2)$(7.5)
Foreign currency denominated debtNonoperating income/expense$725.8 $(989.7)$47.1 $33.7 
Foreign currency derivativesNonoperating income/expense40.2 (12.3)
Foreign currency derivatives(1)
Interest expense$14.7 $14.7 
Net investment hedges$766.0 $(1,002.0)$47.1 $33.7 $14.7 $14.7 
Foreign currencyNonoperating income/expense$9.4 $(29.0)
EquitySelling, general & administrative expenses99.3 44.4 
EquityOther operating income/ expense, net(11.3)(16.0)
Undesignated derivatives$97.4 $(0.6)
(1)The amount of gain (loss) recognized in income related to components excluded from effectiveness testing.